Jiangsu Province Centers for Disease Control and Prevention
- Country
- People's Republic of China
- Ownership
- Private
- Employees
- -
- Market Cap
- -
- Website
- http://www.jstd.gov.cn/
Phase Ⅱ Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
- Conditions
- Streptococcus Pneumoniae Pneumonia
- Interventions
- Biological: low dose-1Biological: low dose-2Biological: high doseBiological: positive control
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Target Recruit Count
- 992
- Registration Number
- NCT07035054
- Locations
- 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China
PhaseⅠClinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine
- Conditions
- Streptococcus Pneumoniae Pneumonia
- Interventions
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-18
- Target Recruit Count
- 240
- Registration Number
- NCT07025876
- Locations
- 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China
The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine
- Conditions
- Influenza
- Interventions
- Biological: Intranasal Influenza Live Attenuated Vaccine
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2025-04-24
- Target Recruit Count
- 200
- Registration Number
- NCT06609811
- Locations
- 🇨🇳
Haizhou District Center for Disease Control and Prevention, Lianyungang, Jiangsu, China
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
- Conditions
- PertussisDiphtheriaTetanusHaemophilus Influenzae Type B InfectionPolio
- First Posted Date
- 2024-09-20
- Last Posted Date
- 2024-09-20
- Target Recruit Count
- 785
- Registration Number
- NCT06605755
- Locations
- 🇨🇳
Jingsu Provincial Centre of Disease Control and Prevention, Nanjing, Jiangsu, China
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
- Conditions
- Hand, Foot and Mouth Disease
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-01-17
- Target Recruit Count
- 510
- Registration Number
- NCT06209398
- Locations
- 🇨🇳
Jiangsu Province Centers for Disease Control and Prevention, Nanjing, Jiangsu, China
Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults
- Conditions
- COVID-19
- First Posted Date
- 2023-05-11
- Last Posted Date
- 2023-05-22
- Target Recruit Count
- 10000
- Registration Number
- NCT05855408
- Locations
- 🇨🇳
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China
Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens
- Conditions
- Plague
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2022-04-15
- Target Recruit Count
- 720
- Registration Number
- NCT05330624
- Locations
- 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
- Conditions
- Influenza
- First Posted Date
- 2022-04-06
- Last Posted Date
- 2022-08-17
- Target Recruit Count
- 252
- Registration Number
- NCT05313893
- Locations
- 🇨🇳
Donghai County Center for Disease Control and Prevention, Lianyungang, Jiangsu, China
Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy Adults
- Conditions
- COVID-19
- First Posted Date
- 2022-04-06
- Last Posted Date
- 2022-04-06
- Target Recruit Count
- 1050
- Registration Number
- NCT05313646
- Locations
- 🇨🇳
Guanyun Center for Disease Control and Prevention, Lianyungang, Jiangsu, China
Heterologous Boost Immunization with Ad5-nCoV After Three-dose Priming with an Inactivated SARS-CoV-2 Vaccine
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2025-02-21
- Target Recruit Count
- 362
- Registration Number
- NCT05303584
- Locations
- 🇨🇳
Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu, China